MXPA04004224A - Rsv proteins, antibodies, compositions, methods and uses. - Google Patents

Rsv proteins, antibodies, compositions, methods and uses.

Info

Publication number
MXPA04004224A
MXPA04004224A MXPA04004224A MXPA04004224A MXPA04004224A MX PA04004224 A MXPA04004224 A MX PA04004224A MX PA04004224 A MXPA04004224 A MX PA04004224A MX PA04004224 A MXPA04004224 A MX PA04004224A MX PA04004224 A MXPA04004224 A MX PA04004224A
Authority
MX
Mexico
Prior art keywords
methods
antibodies
rsv
compositions
uses
Prior art date
Application number
MXPA04004224A
Other languages
Spanish (es)
Inventor
Bernard Scallon
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US33608101P priority Critical
Priority to US33783801P priority
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Priority to PCT/US2002/034154 priority patent/WO2003063767A2/en
Publication of MXPA04004224A publication Critical patent/MXPA04004224A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • C07K16/1027Paramyxoviridae, e.g. respiratory syncytial virus
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Abstract

The present invention relates to at least one novel RSV proteins, antibodies, including isolated nucleic acids that encode at least one RSV protein or antibody, RSV vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
MXPA04004224A 2001-11-02 2002-10-26 Rsv proteins, antibodies, compositions, methods and uses. MXPA04004224A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US33608101P true 2001-11-02 2001-11-02
US33783801P true 2001-11-13 2001-11-13
PCT/US2002/034154 WO2003063767A2 (en) 2001-11-02 2002-10-26 Rsv proteins, antibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
MXPA04004224A true MXPA04004224A (en) 2005-03-31

Family

ID=27668884

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004224A MXPA04004224A (en) 2001-11-02 2002-10-26 Rsv proteins, antibodies, compositions, methods and uses.

Country Status (6)

Country Link
EP (1) EP1501870A4 (en)
JP (1) JP2005522996A (en)
AU (1) AU2002365925A1 (en)
CA (1) CA2466025A1 (en)
MX (1) MXPA04004224A (en)
WO (1) WO2003063767A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2418360T3 (en) 1999-04-09 2013-08-13 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of a molecule immunofunctional
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
AU2004277466B2 (en) 2003-10-01 2010-04-01 Kyowa Hakko Kirin Co., Ltd. Method of stabilizing antibody and stabilized solution-type antibody preparation
JP5575377B2 (en) 2008-07-18 2014-08-20 シスメックス株式会社 rs virus detection kit and immuno-chromatographic test device with anti rs virus monoclonal antibodies, as well as novel anti-rs virus monoclonal antibody

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762905A (en) * 1992-09-16 1998-06-09 The Scripps Research Institute Human neutralizing monoclonal antibodies to respiratory syncytial virus
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
JP2001510329A (en) * 1996-11-01 2001-07-31 スミスクライン・ビーチャム・コーポレイション Human monoclonal antibody
AU2001240020B9 (en) * 2000-03-01 2008-12-04 Medimmune, Llc High potency recombinant antibodies and method for producing them

Also Published As

Publication number Publication date
JP2005522996A (en) 2005-08-04
EP1501870A2 (en) 2005-02-02
CA2466025A1 (en) 2003-08-07
AU2002365925A1 (en) 2003-09-02
WO2003063767A2 (en) 2003-08-07
WO2003063767A3 (en) 2004-12-02
EP1501870A4 (en) 2006-05-03

Similar Documents

Publication Publication Date Title
EA015166B1 (en) Immunogen sclerostin peptides (sost), inducing formation of specific antibodies
MX336118B (en) Hybrid and tandem expression of neisserial proteins.
WO2002024909A3 (en) Receptor nucleic acids and polypeptides
ZA200308861B (en) Methods of administering anti-TNFalpha antibodies.
EA200601603A1 (en) Antibody mimetic glp-1, compositions, methods and uses
ME00185B (en) Specific binding agents of human angiopoietin-2
WO2005019258A3 (en) Compositions and methods for the treatment of immune related diseases
BR0214168A (en) anti-IL-6 antibodies, compositions, methods and uses
UA87804C2 (en) Human monoclonal antibody that specifically binds to insulin-like growth factor i receptor (igf-ir)
EP2343086A3 (en) Antibodies to CD40
PT2163562E (en) Il-1beta binding antibodies and fragments thereof
WO1999038972A8 (en) Human genes and gene expression products ii
NZ541361A (en) Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920
WO2007067730A3 (en) Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
HRP20030088A2 (en) Anti-dual integrin antibodies, compositions, methods and uses
NZ524145A (en) Anti-IL-12 mammalian, chimeric, humanized or CDR-grafted antibodies for use in treating IL-12 related conditions such as psoriasis and multiple sclerosis
NZ512105A (en) Human TSLP DNA and polypeptides
WO2003085089A3 (en) Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
NZ546287A (en) Human epo mimetic hinge core mimetibodies, compositions, methods and uses
MXPA03003666A (en) Genes encoding novel proteins with pesticidal activity against coleopterans.
WO2002014358A3 (en) Novel secreted proteins and their uses
MX342595B (en) Human anti-il-23 antibodies, compositions, methods and uses.
WO2003068920A8 (en) Humanized gm-csf antibodies
WO2001072976A3 (en) 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor

Legal Events

Date Code Title Description
FA Abandonment or withdrawal